Rare diseases
Investigational molecules
Locations
Back to Czechia187 clinical trials in Plzen, Czechia across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
CzechiaStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
CzechiaStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
CzechiaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
CzechiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
CzechiaWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
CzechiaA study to evaluate the effects of obicetrapib and ezetimibe on cholesterol levels in adults with type 2 diabetes or metabolic syndrome
CzechiaEvaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers
CzechiaA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
CzechiaTesting Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment
CzechiaA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood cancers and related conditions, including studies on innovative treatments for acute myeloid leukemia, chronic lymphocytic leukemia, and multiple myeloma. These trials are evaluating new therapeutic combinations and personalized treatment approaches.
Clinical investigations targeting respiratory conditions, with particular emphasis on treatments for chronic obstructive pulmonary disease, asthma, and chronic rhinosinusitis. Research focuses on evaluating novel therapeutics and their effectiveness in managing symptoms.
Innovative research addressing psychiatric disorders, including studies on generalized anxiety disorder and major depressive disorder. These trials are evaluating new therapeutic approaches and combination treatments to improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
